Affinity Asset Advisors, LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 91Value: $976.7MLatest: 2025Q1

Affinity Asset Advisors, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 91 holdings worth $1.0 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "NUVL",
  "AXSM",
  "EWTX",
  "TRVI",
  "CNTA",
  "ALKS",
  "INSM",
  "NAMS",
  "MDGL",
  "ALNY",
  "ABVX",
  "OLMA",
  "CATX",
  "MIRM",
  "THRD",
  "TVTX",
  "TRML",
  "NRIX",
  "MLYS",
  "KYMR",
  "ADGM",
  "AKBA",
  "ALLK",
  "AVTX",
  "AVR",
  "ESTA",
  "GERN",
  "GALT",
  "SYRE",
  "APGE",
  "AUTL",
  "NBIX",
  null,
  "LXEO",
  "MNPR",
  null,
  "NXTC",
  "NKTX",
  "OVID",
  "OKUR",
  "PRQR",
  "QTTB",
  "RPTX",
  "STRO",
  null,
  null,
  "RZLT",
  "EXEL",
  "TEVA",
  "IBRX",
  "ZURA",
  null,
  "SPY",
  null,
  null,
  "AMGN",
  null,
  null,
  null,
  "PTGX",
  "MBX",
  null,
  "SLNO",
  "ACLX",
  "QURE",
  "OMER",
  "ETNB",
  "WVE",
  "ROIV",
  null,
  "CNTX",
  "ERAS",
  "INZY",
  "VRNA",
  "VKTX",
  "VRDN",
  "XENE",
  "ORKA",
  "VERA",
  "IMVT",
  "PCVX",
  null,
  "BDTX",
  "BBIO",
  "CMPX",
  "CORT",
  "CRNX",
  "CGEM",
  "IWM",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-14
Total Holdings: 91
Total Value: 976714470
Accession Number: 0001999371-25-006074
Form Type: 13F-HR
CIK: affinity-asset-advisors
Manager Name: Affinity-Asset-Advisors

Data Enrichment

86% identified

78 identified13 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

91 positions • $976.7M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 1 of 5

Sort by:

SPDR S&P 500 ETF TRUST

SPY|78462F103

Shares:400.0K

Value:$223.8M

% of Portfolio:22.9% ($223.8M/$976.7M)

464287655

IWM|464287655

Shares:300.0K

Value:$59.8M

% of Portfolio:6.1% ($59.8M/$976.7M)

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:1.3M

Value:$44.6M

% of Portfolio:4.6% ($44.6M/$976.7M)

Apogee Therapeutics, Inc.

APGE|03770N101

Shares:1.2M

Value:$43.0M

% of Portfolio:4.4% ($43.0M/$976.7M)

78464A870

Shares:500.0K

Value:$40.5M

% of Portfolio:4.2% ($40.5M/$976.7M)

Verona Pharma plc

VRNA|925050106

Shares:615.0K

Value:$39.0M

% of Portfolio:4.0% ($39.0M/$976.7M)

Arcellx, Inc.

ACLX|03940C100

Shares:530.0K

Value:$34.8M

% of Portfolio:3.6% ($34.8M/$976.7M)

Alkermes plc.

ALKS|G01767105

Shares:1.0M

Value:$33.0M

% of Portfolio:3.4% ($33.0M/$976.7M)

Nuvalent, Inc.

NUVL|670703107

Shares:460.0K

Value:$32.6M

% of Portfolio:3.3% ($32.6M/$976.7M)

MADRIGAL PHARMACEUTICALS, INC.

MDGL|558868105

Shares:80.0K

Value:$26.5M

% of Portfolio:2.7% ($26.5M/$976.7M)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:1.5M

Value:$22.2M

% of Portfolio:2.3% ($22.2M/$976.7M)

AMGEN INC

AMGN|031162100

Shares:70.0K

Value:$21.8M

% of Portfolio:2.2% ($21.8M/$976.7M)

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA|881624209

Shares:1.4M

Value:$21.5M

% of Portfolio:2.2% ($21.5M/$976.7M)

Travere Therapeutics, Inc.

TVTX|89422G107

Shares:1.1M

Value:$19.2M

% of Portfolio:2.0% ($19.2M/$976.7M)

ALNYLAM PHARMACEUTICALS, INC.

ALNY|02043Q107

Shares:55.0K

Value:$14.9M

% of Portfolio:1.5% ($14.9M/$976.7M)

Wave Life Sciences Ltd.

WVE|Y95308105

Shares:1.8M

Value:$14.7M

% of Portfolio:1.5% ($14.7M/$976.7M)

682143AG7

Shares:—

Value:$14.3M

% of Portfolio:1.5% ($14.3M/$976.7M)

Merus N.V.

MRUS|N5749R100

Shares:322.0K

Value:$13.6M

% of Portfolio:1.4% ($13.6M/$976.7M)

Axsome Therapeutics, Inc.

AXSM|05464T104

Shares:100.0K

Value:$11.7M

% of Portfolio:1.2% ($11.7M/$976.7M)

48576UAA4

Shares:—

Value:$11.6M

% of Portfolio:1.2% ($11.6M/$976.7M)

Instrument	Shares		Other Manager	Value	% of Portfolio
SPDR S&P 500 ETF TRUST(SPYcusip78462F103)	400.0K	QoQ NEW(+400.0K) YoY NEW(+400.0K)	All Managers (Combined)	$223.8M	22.9% ($223.8M/$976.7M)	QoQ NEW(+$223.8M) YoY NEW(+$223.8M)
(IWMcusip464287655)	300.0K	QoQ NEW(+300.0K) YoY NEW(+300.0K)	All Managers (Combined)	$59.8M	6.1% ($59.8M/$976.7M)	QoQ NEW(+$59.8M) YoY NEW(+$59.8M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	1.3M	QoQ +14.37% (-166.9K) YoY +58.60% (+490.8K)	All Managers (Combined)	$44.6M	4.6% ($44.6M/$976.7M)	QoQ -2.10% (-$960.2K) YoY +23.60% (+$8.5M)
Apogee Therapeutics, Inc.(APGEcusip03770N101)	1.2M	QoQ +23.55% (+219.5K) YoY +94.42% (+559.1K)	All Managers (Combined)	$43.0M	4.4% ($43.0M/$976.7M)	QoQ +1.89% (+$801.5K) YoY +9.31% (+$3.7M)
(cusip78464A870)✕	500.0K	QoQ -33.33% (-250.0K) YoY -28.57% (-200.0K)	All Managers (Combined)	$40.5M	4.2% ($40.5M/$976.7M)	QoQ -39.96% (-$27.0M) YoY -38.95% (-$25.9M)
Verona Pharma plc(VRNAcusip925050106)	615.0K	QoQ -6.81% (-45.0K) YoY -24.80% (-202.8K)	All Managers (Combined)	$39.0M	4.0% ($39.0M/$976.7M)	QoQ +27.39% (-$8.4M) YoY +196.72% (-$25.9M)
Arcellx, Inc.(ACLXcusip03940C100)	530.0K	QoQ +24.70% (+105.0K) YoY +76.66% (+230.0K)	All Managers (Combined)	$34.8M	3.6% ($34.8M/$976.7M)	QoQ +6.67% (+$2.2M) YoY +66.63% (+$13.9M)
Alkermes plc.(ALKScusipG01767105)	1.0M	QoQ -9.09% (-100.0K) YoY +1233.33% (+925.0K)	All Managers (Combined)	$33.0M	3.4% ($33.0M/$976.7M)	QoQ +4.37% (-$1.4M) YoY +1526.40% (+$31.0M)
Nuvalent, Inc.(NUVLcusip670703107)	460.0K	QoQ +61.40% (+175.0K) YoY +206.66% (+310.0K)	All Managers (Combined)	$32.6M	3.3% ($32.6M/$976.7M)	QoQ +46.22% (+$10.3M) YoY +189.63% (+$21.4M)
MADRIGAL PHARMACEUTICALS, INC.(MDGLcusip558868105)	80.0K	QoQ -3.03% (-2.5K) YoY -30.43% (-35.0K)	All Managers (Combined)	$26.5M	2.7% ($26.5M/$976.7M)	QoQ +4.09% (-$1.0M) YoY -13.71% (-$4.2M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	1.5M	QoQ +41.12% (+450.7K) YoY +86.22% (+716.1K)	All Managers (Combined)	$22.2M	2.3% ($22.2M/$976.7M)	QoQ +21.15% (+$3.9M) YoY +136.98% (+$12.9M)
AMGEN INC(AMGNcusip031162100)	70.0K	QoQ +133.33% (+40.0K) YoY NEW(+70.0K)	All Managers (Combined)	$21.8M	2.2% ($21.8M/$976.7M)	QoQ +178.90% (+$14.0M) YoY NEW(+$21.8M)
TEVA PHARMACEUTICAL INDUSTRIES LTD(TEVAcusip881624209)	1.4M	QoQ 0.00% (-0) YoY 0.00% (+0)	All Managers (Combined)	$21.5M	2.2% ($21.5M/$976.7M)	QoQ -30.26% (-$9.3M) YoY +8.92% (+$1.8M)
Travere Therapeutics, Inc.(TVTXcusip89422G107)	1.1M	QoQ +435.00% (+870.0K) YoY +756.00% (+945.0K)	All Managers (Combined)	$19.2M	2.0% ($19.2M/$976.7M)	QoQ +450.35% (+$15.7M) YoY +1889.56% (+$18.2M)
ALNYLAM PHARMACEUTICALS, INC.(ALNYcusip02043Q107)	55.0K	QoQ NEW(+55.0K) YoY +37.50% (+15.0K)	All Managers (Combined)	$14.9M	1.5% ($14.9M/$976.7M)	QoQ NEW(+$14.9M) YoY +148.42% (+$8.9M)
Wave Life Sciences Ltd.(WVEcusipY95308105)	1.8M	QoQ +21.66% (-325.0K) YoY +536.80% (+1.5M)	All Managers (Combined)	$14.7M	1.5% ($14.7M/$976.7M)	QoQ -20.52% (-$3.8M) YoY +733.94% (+$13.0M)
(cusip682143AG7)✕	—	QoQ - YoY -	All Managers (Combined)	$14.3M	1.5% ($14.3M/$976.7M)	QoQ -2.32% (-$339.7K) YoY +87.03% (+$6.6M)
Merus N.V.(MRUScusipN5749R100)	322.0K	QoQ -17.28% (-67.3K) YoY NEW(+322.0K)	All Managers (Combined)	$13.6M	1.4% ($13.6M/$976.7M)	QoQ -17.20% (-$2.8M) YoY NEW(+$13.6M)
Axsome Therapeutics, Inc.(AXSMcusip05464T104)	100.0K	QoQ +33.33% (+25.0K) YoY -28.44% (-39.8K)	All Managers (Combined)	$11.7M	1.2% ($11.7M/$976.7M)	QoQ +83.79% (+$5.3M) YoY +4.57% (-$510.3K)
(cusip48576UAA4)✕	—	QoQ - YoY NEW	All Managers (Combined)	$11.6M	1.2% ($11.6M/$976.7M)	QoQ -2.15% (-$256.3K) YoY NEW(+$11.6M)